KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Land & Improvements (2016 - 2022)

Historic Land & Improvements for Bio-Rad Laboratories (BIO) over the last 14 years, with Q4 2022 value amounting to $27.8 million.

  • Bio-Rad Laboratories' Land & Improvements fell 48.32% to $27.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $27.8 million, marking a year-over-year decrease of 48.32%. This contributed to the annual value of $27.8 million for FY2022, which is 48.32% down from last year.
  • Per Bio-Rad Laboratories' latest filing, its Land & Improvements stood at $27.8 million for Q4 2022, which was down 48.32% from $27.9 million recorded in Q4 2021.
  • Bio-Rad Laboratories' 5-year Land & Improvements high stood at $27.9 million for Q4 2021, and its period low was $25.2 million during Q4 2018.
  • In the last 5 years, Bio-Rad Laboratories' Land & Improvements had a median value of $25.7 million in 2020 and averaged $26.4 million.
  • Its Land & Improvements has fluctuated over the past 5 years, first soared by 3971.49% in 2018, then plummeted by 48.32% in 2022.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Land & Improvements stood at $25.2 million in 2018, then grew by 0.12% to $25.2 million in 2019, then grew by 2.08% to $25.7 million in 2020, then rose by 8.55% to $27.9 million in 2021, then fell by 0.48% to $27.8 million in 2022.
  • Its last three reported values are $27.8 million in Q4 2022, $27.9 million for Q4 2021, and $25.7 million during Q4 2020.